Table 1 Clinical characteristics of study participants
|  | Non-obese (N = 14) | Obese (N = 14) | P value |
|---|---|---|---|
Men/Women | 7/7 | 8/6 | Â |
Age, years | 54.2 ± 6.8 | 50.2 ± 6.2 | 1.3 × 10−1 |
BMI, kg/m2 | 24.7 ± 2.4 | 35.1 ± 2.8 | 5.1 × 10−11 |
Weight, kg | 74.5 ± 14.2 | 111.3 ± 9.0 | 1.2 × 10−9 |
Hip circumference, cm | 100.6 ± 4.7 | 119.6 ± 6.9 | 5.7 × 10−9 |
Waist circumference, cm | 85.9 ± 10.2 | 116.1 ± 8.6 | 6.2 × 10−9 |
Android fat mass, kg | 1.7 ± 7.1 | 4.9 ± 1.0 | 4.3 × 10−10 |
Gynoid fat mass, kg | 4.0 ± 1.3 | 7.0 ± 2.0 | 6.5 × 10−5 |
Whole body fat mass, kg | 20.0 ± 6.0 | 42.7 ± 8.7 | 1.7 × 10−8 |
Whole body fat-free mass, kg | 51.4 ± 13.3 | 63.9 ± 11.9 | 1.4 × 10−2 |
Fasting glucose, mmol/L | 4.8 ± 0.6 | 5.0 ± 0.4 | 2.3 × 10−1 |
2-h glucose, mmol/La | 5.2 ± 1.4 | 5.5 ± 1.4 | 5.6 × 10−1 |
Fasting insulin, pmol/L | 32.1 ± 13.3 | 92.7 ± 30.3 | 3.8 × 10−7 |
2-h insulin, pmol/La | 230.1 ± 155.3 | 441.9 ± 287.0 | 2.4 × 10−2 |
HOMA-IR | 1.0 ± 0.5 | 3.0 ± 1.1 | 1.8 × 10−6 |
HOMA-β, % | 74.4 ± 26.7 | 184.4 ± 74.8 | 2.4 × 10−5 |
P-Cholesterol-total, mmol/L | 5.5 ± 1.0 | 5.2 ± 0.8 | 4.3 × 10−1 |
P-Cholesterol-HDL, mmol/L | 1.7 ± 0.5 | 1.3 ± 0.3 | 1.7 × 10−2 |
P-Cholesterol-LDL, mmol/L | 3.3 ± 0.9 | 3.3 ± 0.6 | 9.8 × 10−1 |
Systolic blood pressure, mmHg | 134.3 ± 12.0 | 138.5 ± 18.1 | 4.7 × 10−1 |
Diastolic blood pressure, mmHg | 85.6 ± 9.5 | 91.6 ± 9.1 | 9.8 × 10−1 |
Pulse, beats/min | 59.5 ± 12.4 | 66.6 ± 8.4 | 8.6 × 10−11 |
VO2 max per kg, mL/min/kg | 32.6 ± 11.4 | 22.2 ± 4.4 | 3.8 × 10−3 |